Additionally, the currently approved GLP-1 RA for obesity treatment are in injectable form and some people may be reluctant to consider injectable treatments [15]
Aggregation changes the apparent molecular weight and can reduce bioactivity
Nat Biotechnol 40 , 11641165 (2022)
Life Sci 264:118645 Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A (2022a) New insights into cellular links between sodiumglucose cotransporter-2 inhibitors and ketogenesis
CMMI BALANCE Demonstration Program: Medicaid In the meantime, the BALANCE demonstration program for state Medicaid programs will continue
Such approaches may help refine nutritional strategies and improve the long-term metabolic durability of pharmacological obesity treatment